BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 14191274)

  • 1. ENDOGENOUS COPPER CLEARANCE IN WILSON'S DISEASE: A STUDY OF THE MODE OF ACTION OF PENICILLAMINE.
    WALSHE JM
    Clin Sci; 1964 Jun; 26():461-9. PubMed ID: 14191274
    [No Abstract]   [Full Text] [Related]  

  • 2. [WILSON'S DISEASE TREATED BY PENICILLAMINE].
    BERNHEIM M; FREYCON MT; PELLET H; DEFFRENNE P; LAMIT J
    Pediatrie; 1964; 19():373-5. PubMed ID: 14147228
    [No Abstract]   [Full Text] [Related]  

  • 3. COPPER BALANCE STUDIES DURING THE TREATMENT OF PATIENTS WITH WILSON'S DISEASE.
    TU JB; BLACKWELL RQ; WATTEN RH
    Metabolism; 1965 Jun; 14():653-66. PubMed ID: 14293521
    [No Abstract]   [Full Text] [Related]  

  • 4. [HEPATOCEREBRAL OR HEPATOLENTICULAR DEGENERATION].
    AKSOY M; BIYAL F; SECER F; CAKIRGOEZ C; CETINGIL AI
    Tip Fak Mecm; 1964; 27():37-55. PubMed ID: 14140395
    [No Abstract]   [Full Text] [Related]  

  • 5. BASAL COPPER EXCRETION IN WILSON'S DISEASE.
    WARREN CB; BROUGHTON PM
    Arch Dis Child; 1964 Jun; 39(205):265-7. PubMed ID: 14169457
    [No Abstract]   [Full Text] [Related]  

  • 6. D-PENICILLAMINE, WITH PARTICULAR RELATION TO WILSON'S DISEASE.
    SCHEINBERG IH
    J Chronic Dis; 1964 Apr; 17():293-8. PubMed ID: 14141837
    [No Abstract]   [Full Text] [Related]  

  • 7. [True hepatic Wilson's disease].
    Ciravegna B; Giacchino R; Marazzi MG
    Pediatr Med Chir; 1983; 5(1-2):7-10. PubMed ID: 6634446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HEPATOLENTICULAR DEGENERATION (WILSON'S DISEASE). TWO DIFFERENT COMPONENTS.
    DENNY-BROWN D
    N Engl J Med; 1964 May; 270():1149-56. PubMed ID: 14129061
    [No Abstract]   [Full Text] [Related]  

  • 9. HEPATOLENTICULAR DEGENERATION: OBSERVATIONS ON A CASE TREATED WITH D-PENICILLAMINE.
    HERRING VG; KLATSKIN G; BRANDT IK
    J Pediatr; 1963 Oct; 63():550-60. PubMed ID: 14074413
    [No Abstract]   [Full Text] [Related]  

  • 10. Relation of ceruloplasmin and plasma copper to hepatolenticular degeneration (Wilson's disease).
    SCHEINBERG IH
    Prog Neurobiol (1956); 1956; 1():52-63. PubMed ID: 13359521
    [No Abstract]   [Full Text] [Related]  

  • 11. COPPER BALANCE STUDIES IN WILSON'S DISEASE (HEPATOLENTICULAR DEGENERATION). OBSERVATIONS ON THE EFFECT OF PENICILLAMINE, CARBO-RESIN AND POTASSIUM SULFIDE.
    GOLDSTEIN NP; RANDALL RV; GROSS JB; MCGUCKIN WF
    Trans Am Neurol Assoc; 1963; 88():221-2. PubMed ID: 14272232
    [No Abstract]   [Full Text] [Related]  

  • 12. Urinary copper excretion before and after oral intake of d-penicillamine in parents of patients with Wilson's disease.
    Vieira J; Oliveira PV; Juliano Y; Warde KR; Deguti MM; Barbosa ER; Carrilho FJ; Cancado EL
    Dig Liver Dis; 2012 Apr; 44(4):323-7. PubMed ID: 22169274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pattern of urinary copper excretion and its response to treatment in patients with Wilson's disease.
    Walshe JM
    QJM; 2011 Sep; 104(9):775-8. PubMed ID: 21622540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HEPATO-LENTICULAR DEGENERATION (WILSON'S DISEASE) TREATED BY PENICILLAMINE.
    RICHMOND J; ROSENOER VM; TOMPSETT SL; DRAPER I; SIMPSON JA
    Brain; 1964 Dec; 87():619-38. PubMed ID: 14236007
    [No Abstract]   [Full Text] [Related]  

  • 15. FAMILIAL HEPATIC COPPER STORAGE DISEASE: A VARIANT OF WILSON'S DISEASE.
    FISHER MM; SHERLOCK S
    Arch Dis Child; 1964 Feb; 39(203):14-7. PubMed ID: 14160082
    [No Abstract]   [Full Text] [Related]  

  • 16. A critical evaluation of copper metabolism in Indian Wilson's disease children with special reference to their phenotypes and relatives.
    Prasad R; Kaur G; Walia BN
    Biol Trace Elem Res; 1998 Nov; 65(2):153-65. PubMed ID: 9881519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of long term treatment with penicillamine on the copper content in the liver in patients with Wilson's disease.
    Marecek Z; Heyrovský A; Volek V
    Acta Hepatogastroenterol (Stuttg); 1975 Oct; 22(5):292-6. PubMed ID: 1199668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exchange of ceruloplasmin copper with ionic Cu64 with reference to Wilson's disease.
    SCHEINBERG IH; MORELL AG
    J Clin Invest; 1957 Aug; 36(8):1193-201. PubMed ID: 13463081
    [No Abstract]   [Full Text] [Related]  

  • 19. [CURRENT ASPECTS OF WILSON'S DISEASE].
    PETIT H
    Lille Med; 1964 Oct; 9():750-8. PubMed ID: 14210920
    [No Abstract]   [Full Text] [Related]  

  • 20. [COPPER METABOLISM AND WILSON'S DISEASE].
    LANGE J
    Verh Dtsch Ges Inn Med; 1964; 70():330-7. PubMed ID: 14294237
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.